Ake Lu
PhD
Research Scientist
👥Biography 个人简介
Ake Lu co-developed GrimAge, considered the most powerful epigenetic predictor of lifespan and cancer mortality, which uses DNA methylation surrogates of plasma proteins including PAI-1 and smoking pack-years. GrimAge has been validated across multiple cohorts as a superior predictor of time-to-cancer compared to first-generation clocks. His technical innovations in methylation-based plasma protein estimation have expanded the biomarker toolkit for cancer risk stratification.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ake Lu 的研究动态
Follow Ake Lu's research updates
留下邮箱，当我们发布与 Ake Lu（Altos Labs）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment